-
1 Comment
Lianluo Smart Limited is currently in a long term uptrend where the price is trading 53.7% above its 200 day moving average.
From a valuation standpoint, the stock is 94.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 79.2.
Lianluo Smart Limited's total revenue sank by 0.0% to $141K since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 46.4% to $-337K since the same quarter in the previous year.
Based on the above factors, Lianluo Smart Limited gets an overall score of 3/5.
Industry | Medical Devices |
---|---|
Exchange | NASDAQ |
CurrencyCode | USD |
ISIN | VGG5478K1185 |
Sector | Healthcare |
PE Ratio | None |
---|---|
Target Price | None |
Dividend Yield | 0.0% |
Market Cap | 45M |
Beta | -0.12 |
Lianluo Smart Limited, together with its subsidiaries, designs, develops, markets, and distributes medical products primarily in China and internationally. The company offers medical devices, including wearable sleep respiratory solutions, general hospital products, medical compressors, and related supporting products. It also provides technical services in relation to the detection and analysis of obstructive sleep apnea syndrome to hospitals and medical centers through medical wearable devices. In addition, the company distributes medical products, such as sleep apnea machines. Lianluo Smart Limited sells its products primarily through distributors; and directly to hospitals, physical examination centers, and sleep centers, as well as to individual consumers. The company was formerly known as Dehaier Medical Systems Limited and changed its name to Lianluo Smart Limited in November 2016. Lianluo Smart Limited was incorporated in 2003 and is headquartered in Beijing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for LLIT using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025